同源康医药-B获纳入恒生生物科技指数成份股

格隆汇
19 May

格隆汇5月19日丨同源康医药-B(02410.HK)发布公告,公司的H股已获选纳入恒生生物科技指数成份股,自2025年6月9日起生效。恒生生物科技指数旨在反映于香港上市的生物科技公司的整体表现。董事会认为,公司被纳入恒生生物科技指数成份股,反映了资本市场对公司业务表现及增长前景的认可。董事会相信,此举将有助于扩大公司股东基础,提升H股的交易流动性,并进一步增强公司的声誉及品牌知名度。

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10